IDEAS home Printed from https://ideas.repec.org/r/sae/medema/v9y1989i2p142-149.html
   My bibliography  Save this item

Quality-adjusted Life Years, Utility Theory, and Healthy-years Equivalents

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. Rutten, Frans & Bleichrodt, Han & Brouwer, Werner & Koopmanschap, Marc & Schut, Erik, 2001. "Handbook of Health Economics," Journal of Health Economics, Elsevier, vol. 20(5), pages 855-879, September.
  2. Laura Muñoz-Bermejo & María José González-Becerra & Sabina Barrios-Fernández & Salvador Postigo-Mota & María del Rocío Jerez-Barroso & Juan Agustín Franco Martínez & Belén Suárez-Lantarón & Diego Muño, 2022. "Cost-Effectiveness of the Comprehensive Interdisciplinary Program-Care in Informal Caregivers of People with Alzheimer’s Disease," IJERPH, MDPI, vol. 19(22), pages 1-16, November.
  3. Alberto Manelli & Oscar Domenichelli & Roberta Pace & Martina Vallesi, 2016. "HTA in the nutritional care: investments? efficiency and effectiveness," RIVISTA DI STUDI SULLA SOSTENIBILITA', FrancoAngeli Editore, vol. 2016(2), pages 57-68.
  4. Hougaard, Jens Leth & Moreno-Ternero, Juan D. & Østerdal, Lars Peter, 2013. "A new axiomatic approach to the evaluation of population health," Journal of Health Economics, Elsevier, vol. 32(3), pages 515-523.
  5. Hansen, Kristian S. & Moreno-Ternero, Juan D. & Østerdal, Lars P., 2023. "Productivity and quality-adjusted life years: QALYs, PALYs and beyond," Working Papers 11-2023, Copenhagen Business School, Department of Economics.
  6. Diecidue, E. & Schmidt, U. & Wakker, P.P., 2000. "A Theory of the Gambling Effect," Other publications TiSEM c975e1b4-2319-429d-a68e-f, Tilburg University, School of Economics and Management.
  7. Jorge Carlos-Vivas & Jorge Pérez-Gómez & Serafín Delgado-Gil & José Carlos Campos-López & Manuel Granado-Sánchez & Jorge Rojo-Ramos & Laura Muñoz-Bermejo & Sabina Barrios-Fernandez & María Mendoza-Muñ, 2020. "Cost-Effectiveness of “Tele-Square Step Exercise” for Falls Prevention in Fibromyalgia Patients: A Study Protocol," IJERPH, MDPI, vol. 17(3), pages 1-16, January.
  8. Broome, John, 1996. "The Value of Life and the Value of Population," Journal of Population Economics, Springer;European Society for Population Economics, vol. 9(1), pages 3-18, February.
  9. James Hammitt, 2013. "Admissible utility functions for health, longevity, and wealth: integrating monetary and life-year measures," Journal of Risk and Uncertainty, Springer, vol. 47(3), pages 311-325, December.
  10. Hoel, Michael, 2007. "What should (public) health insurance cover?," Journal of Health Economics, Elsevier, vol. 26(2), pages 251-262, March.
  11. Drummond, Michael & Stoddart, Greg, 1995. "Assessment of health producing measures across different sectors," Health Policy, Elsevier, vol. 33(3), pages 219-231, September.
  12. Magnus Johannesson & Joseph S. Pliskin & Milton C. Weinstein, 1993. "Are Healthy-years Equivalents an Improvement over Quality-adjusted Life Years?," Medical Decision Making, , vol. 13(4), pages 281-286, December.
  13. Bas Janssen & Mark Oppe & Matthijs Versteegh & Elly Stolk, 2013. "Introducing the composite time trade-off: a test of feasibility and face validity," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 14(1), pages 5-13, July.
  14. Carmen Herrero Blanco, 2001. "Individual Evidence Of Independence In Health Profiles Evaluation," Working Papers. Serie AD 2001-20, Instituto Valenciano de Investigaciones Económicas, S.A. (Ivie).
  15. Stavros Petrou, 2003. "Methodological issues raised by preference‐based approaches to measuring the health status of children," Health Economics, John Wiley & Sons, Ltd., vol. 12(8), pages 697-702, August.
  16. Olivier Chanel & Pascale Scapecchi & Jean-Christophe Vergnaud, 2006. "How to correctly assess mortality benefits in public policies," Journal of Environmental Planning and Management, Taylor & Francis Journals, vol. 49(5), pages 759-776.
  17. Bleichrodt, Han, 1997. "Health utility indices and equity considerations," Journal of Health Economics, Elsevier, vol. 16(1), pages 65-91, February.
  18. Afschin Gandjour, 2008. "Incorporating feelings related to the uncertainty about future health in utility measurement," Health Economics, John Wiley & Sons, Ltd., vol. 17(10), pages 1207-1213, October.
  19. Spencer, Anne & Rivero-Arias, Oliver & Wong, Ruth & Tsuchiya, Aki & Bleichrodt, Han & Edwards, Rhiannon Tudor & Norman, Richard & Lloyd, Andrew & Clarke, Philip, 2022. "The QALY at 50: One story many voices," Social Science & Medicine, Elsevier, vol. 296(C).
  20. Han Bleichrodt & Ulrich Schmidt, 2002. "A Context-Dependent Model of the Gambling Effect," Management Science, INFORMS, vol. 48(6), pages 802-812, June.
  21. MORENO-TERNERO, Juan & OSTERDAL, Lars P., 2014. "Normative foundations for equity-sensitive population health evaluation functions," LIDAM Discussion Papers CORE 2014031, Université catholique de Louvain, Center for Operations Research and Econometrics (CORE).
  22. Gafni, Amiram & Birch, Stephen, 1997. "QALYs and HYEs Spotting the differences," Journal of Health Economics, Elsevier, vol. 16(5), pages 601-608, October.
  23. Chen, Ariel & Jacobsen, Kathryn H. & Deshmukh, Ashish A. & Cantor, Scott B., 2015. "The evolution of the disability-adjusted life year (DALY)," Socio-Economic Planning Sciences, Elsevier, vol. 49(C), pages 10-15.
  24. Tony J Culyer & Adam Wagstaff, 1992. "QALYs versus HYEs - a theoretical exposition," Working Papers 099chedp, Centre for Health Economics, University of York.
  25. Catherine Buron & Catherine Le Galès & Anne-Marie Fericelli, 1997. "L'indicateur QALYs à la lumière de la théorie de l'utilité espérée multi-attribut explicitement décomposée," Économie et Prévision, Programme National Persée, vol. 129(3), pages 55-71.
  26. Mark Sculpher & Karl Claxton, 2012. "Real Economics Needs to Reflect Real Decisions," PharmacoEconomics, Springer, vol. 30(2), pages 133-136, February.
  27. World Bank, 2022. "A Welfarist Theory Unifying Monetary and Non-Monetary Poverty Measurement," Policy Research Working Paper Series 10076, The World Bank.
  28. Moreno-Ternero, Juan D. & Platz, Trine Tornøe & Østerdal, Lars Peter, 2023. "QALYs, DALYs, and HALYs: A unifying framework for the evaluation of population health," Journal of Health Economics, Elsevier, vol. 87(C).
  29. Ried, Walter, 1998. "QALYs versus HYEs--what's right and what's wrong. A review of the controversy," Journal of Health Economics, Elsevier, vol. 17(5), pages 607-625, October.
  30. Hansen, Kristian S. & Moreno-Ternero, Juan D. & Østerdal, Lars P., 2024. "Quality- and productivity-adjusted life years: From QALYs to PALYs and beyond," Journal of Health Economics, Elsevier, vol. 95(C).
  31. Mark Sculpher & Amiram Gafni, 2001. "Recognizing diversity in public preferences: The use of preference sub‐groups in cost‐effectiveness analysis," Health Economics, John Wiley & Sons, Ltd., vol. 10(4), pages 317-324, June.
  32. Shiell, Alan, 1997. "Health outcomes are about choices and values: an economic perspective on the health outcomes movement," Health Policy, Elsevier, vol. 39(1), pages 5-15, January.
  33. Juan D. Moreno-Ternero & Lars Peter Østerdal, 2017. "A normative foundation for equity-sensitive health evaluation: The role of relative comparisons of health gains," Journal of Public Economic Theory, Association for Public Economic Theory, vol. 19(5), pages 1009-1025, October.
  34. Efrén Murillo-Zamora & Oliver Mendoza-Cano & Mónica Ríos-Silva & Ramón Alberto Sánchez-Piña & Martha Alicia Higareda-Almaraz & Enrique Higareda-Almaraz & Agustin Lugo-Radillo, 2018. "Disability-Adjusted Life Years for Cancer in 2010–2014: A Regional Approach in Mexico," IJERPH, MDPI, vol. 15(5), pages 1-10, April.
  35. Juan D. Moreno-Ternero & Lars Peter Østerdal, 2023. "Entitlements to continued life and the evaluation of population health," Review of Economic Design, Springer;Society for Economic Design, vol. 27(3), pages 561-579, September.
  36. John Brazier & Paul Dolan & Korina Karampela & Isabel Towers, 2006. "Does the whole equal the sum of the parts? Patient‐assigned utility scores for IBS‐related health states and profiles," Health Economics, John Wiley & Sons, Ltd., vol. 15(6), pages 543-551, June.
  37. James K. Hammitt, 2002. "QALYs Versus WTP," Risk Analysis, John Wiley & Sons, vol. 22(5), pages 985-1001, October.
  38. Herrera-Araujo, Daniel & Hammitt, James K. & Rheinberger, Christoph M., 2020. "Theoretical bounds on the value of improved health," Journal of Health Economics, Elsevier, vol. 72(C).
  39. Buckingham, Ken J. & Devlin, Nancy Joy, 2009. "A note on the nature of utility in time and health and implications for cost utility analysis," Social Science & Medicine, Elsevier, vol. 68(2), pages 362-367, January.
  40. Michael Hoel, 2003. "Allocating health care resources when people are risk averse with respect to life time," Health Economics, John Wiley & Sons, Ltd., vol. 12(7), pages 601-608, July.
  41. Moreno-Terneroy , Juan D & Østerdal, Lars Peter, 2015. "The implications of equal value of life and prioritarianism for the evaluation of population health," DaCHE discussion papers 2015:1, University of Southern Denmark, Dache - Danish Centre for Health Economics.
  42. McNamee, Paul, 2007. "What difference does it make? The calculation of QALY gains from health profiles using patient and general population values," Health Policy, Elsevier, vol. 84(2-3), pages 321-331, December.
  43. Michael Wolfson, 2011. "Health Care is a Knowledge Industry, and Should Be More So," New Directions for Intelligent Government in Canada: Papers in Honour of Ian Stewart, in: Fred Gorbet & Andrew Sharpe (ed.),New Directions for Intelligent Government in Canada: Papers in Honour of Ian Stewart, pages 249-282, Centre for the Study of Living Standards.
  44. Olmstead, Todd & Zeckhauser, Richard, 1999. "The menu-setting problem and subsidized prices: drug formulary illustration," Journal of Health Economics, Elsevier, vol. 18(5), pages 523-550, October.
  45. Adrian Levy & Craig Mitton & Karissa Johnston & Brian Harrigan & Andrew Briggs, 2010. "International Comparison of Comparative Effectiveness Research in Five Jurisdictions," PharmacoEconomics, Springer, vol. 28(10), pages 813-830, October.
  46. Carmen Herrero Blanco, 1998. "- An Alternative Theory Of Health Care Decision Making," Working Papers. Serie AD 1998-15, Instituto Valenciano de Investigaciones Económicas, S.A. (Ivie).
  47. Alan M. Garber, 1999. "Advances in Cost-Effectiveness Analysis of Health Interventions," NBER Working Papers 7198, National Bureau of Economic Research, Inc.
  48. Mike Drummond & Alastair McGuire & Astrid Fletcher, 1993. "Economic evaluation of drug therapy for hypercholesterolaemia in the United Kingdom," Working Papers 104chedp, Centre for Health Economics, University of York.
  49. Johannesson, Magnus, 1995. "Quality-adjusted life-years versus healthy-years equivalents -- A comment," Journal of Health Economics, Elsevier, vol. 14(1), pages 9-16, May.
  50. Claude Le Pen, 1997. "Théorie de l'utilité et mesure des états de santé, le débat QALYs-HYEs," Économie et Prévision, Programme National Persée, vol. 129(3), pages 37-54.
  51. Francisco J. Domínguez-Muñoz & Jorge Carlos-Vivas & Miguel A. Garcia-Gordillo & Santos Villafaina & Fernando Pérez-Escanilla & Carmen Jiménez-Fernández & Dimas Igual-Fraile & Germán J. Rodríguez-Mazón, 2021. "Cost-Effectiveness of a Whole-Body Vibration Program in Patients with Type 2 Diabetes: A Retrospective Study Protocol," Sustainability, MDPI, vol. 13(5), pages 1-12, February.
  52. Bleichrodt, Han, 1995. "QALYs and HYEs: Under what conditions are they equivalent?," Journal of Health Economics, Elsevier, vol. 14(1), pages 17-37, May.
  53. Mason, A.R & Towse, A., 2008. "The Ideas and Influence of Alan Williams: Be Reasonable – Do It My Way," Monographs, Office of Health Economics, number 000242.
  54. Somayeh Sadat & Michael Carter & Brian Golden, 2013. "Theory of constraints for publicly funded health systems," Health Care Management Science, Springer, vol. 16(1), pages 62-74, March.
  55. Hoel, Michael, 2009. "Efficient use of health care resources: The interaction between improved health and reduced health related income loss," HERO Online Working Paper Series 2001:9, University of Oslo, Health Economics Research Programme.
  56. Michael Drummond, 1991. "Economic evaluation of pharmaceuticals: science or marketing?," Working Papers 091chedp, Centre for Health Economics, University of York.
  57. Charles M. Harvey & Lars Peter Østerdal, 2010. "Cardinal Scales for Health Evaluation," Decision Analysis, INFORMS, vol. 7(3), pages 256-281, September.
  58. Gordon B. Hazen, 2007. "Adding Extrinsic Goals to the Quality-Adjusted Life Year Model," Decision Analysis, INFORMS, vol. 4(1), pages 3-16, March.
  59. Krucien, Nicolas & Heidenreich, Sebastian & Gafni, Amiram & Pelletier-Fleury, Nathalie, 2020. "Measuring public preferences in France for potential consequences stemming from re-allocation of healthcare resources," Social Science & Medicine, Elsevier, vol. 246(C).
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.